Results 211 to 220 of about 502,516 (332)

Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy

open access: green, 2008
Ali G. Gharavi   +8 more
openalex   +1 more source

Progress of MXenes‐based responsive materials for soft sensors and actuators

open access: yesResponsive Materials, EarlyView.
MXene, a promising 2D material, excels at mimicking human sensing and feedback system, making it ideal for intelligent robots. This review first covers its structure, properties, and synthesis. It then summarizes recent MXene‐based sensors and actuator.
Peidi Zhou   +10 more
wiley   +1 more source

Cellular Mechanism and Key Insights in Allergen Immunotherapy for Allergic Rhinitis

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Allergic rhinitis (AR) arises from immune responses mediated by immunoglobulin E (IgE) to inhaled allergens, representing one of the most prevalent chronic conditions worldwide. Although AR may not be a serious ailment, it holds clinical relevance as it underpins numerous complications, serves as a major risk factor for suboptimal asthma ...
Zhe Wang   +3 more
wiley   +1 more source

Bacteroides fragilis colonization induces protective systemic IgA. [PDF]

open access: yesMicrobiome
Harris JR   +7 more
europepmc   +1 more source

CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont

open access: green, 2018
Natalia Shulzhenko   +13 more
openalex   +2 more sources

Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy [PDF]

open access: bronze, 2004
Yuansheng Xie   +4 more
openalex   +1 more source

PENGARUH BERKUMUR DENGAN LARUTAN PROBIOTIK TERHADAP KADAR IgA DALAM SALIVA

open access: diamond, 2021
Recita Indraswary   +2 more
openalex   +2 more sources

Long‐Term, Site‐Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72‐Week Real‐World Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba   +6 more
wiley   +1 more source

Oral Immunotherapy-Induced Changes in IgE, IgG, and IgA: A Review of Antibody Isotype Shifts and Their Clinical Relevance in Food Allergy. [PDF]

open access: yesAntibodies (Basel)
Lasagni G   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy